Non-lipid-lowering effects of statins on atherosclerosis (Q34027314)

30 July 2017

1 reference

title

Non-lipid-lowering effects of statins on atherosclerosis (English)

1 reference

30 July 2017

1 reference

Rosenson RS

1

1 reference

30 July 2017

publication date

1 September 1999

1 reference

Current cardiology reports

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

225-232

1 reference

Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death

30 July 2017

cites work

1 reference

12 December 2020

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

12 December 2020

Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component

1 reference

12 December 2020

Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia

1 reference

12 December 2020

Platelet function in hyperlipoproteinemia

1 reference

12 December 2020

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

1 reference

12 December 2020

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

12 December 2020

Effect of atorvastatin on plasma fibrinogen

1 reference

12 December 2020

Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet

1 reference

12 December 2020

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

12 December 2020

The unstable atheroma

1 reference

12 December 2020

Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.

1 reference

12 December 2020

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

1 reference

12 December 2020

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

1 reference

12 December 2020

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

1 reference

12 December 2020

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

12 December 2020

Leucocyte-endothelial interactions and regulation of leucocyte migration.

1 reference

12 December 2020

Effect of statins on C-reactive protein in patients with coronary artery disease

1 reference

12 December 2020

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

1 reference

12 December 2020

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

1 reference

12 December 2020

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

12 December 2020

Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels

1 reference

12 December 2020

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

12 December 2020

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

12 December 2020

Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial

1 reference

12 December 2020

The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium

1 reference

12 December 2020

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

12 December 2020

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Beneficial effects of statins

1 reference

12 December 2020

Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)

1 reference

12 December 2020

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

12 December 2020

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

1 reference

12 December 2020

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

12 December 2020

1 reference

12 December 2020

Atherosclerotic plaque rupture and thrombosis. Evolving concepts

1 reference

12 December 2020

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

12 December 2020

Platelet function and survival in patients wit severe hypercholesterolemia

1 reference

12 December 2020

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

12 December 2020

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

12 December 2020

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

The role of tissue factor pathway inhibitor in a revised coagulation cascade

1 reference

12 December 2020

Nitric oxide as a bifunctional regulator of apoptosis

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

12 December 2020

Cytokines regulate vascular functions related to stability of the atherosclerotic plaque

1 reference

12 December 2020

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

12 December 2020

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

12 December 2020

Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia

1 reference

12 December 2020

Tissue factor and hemostasis

1 reference

12 December 2020

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

1 reference

12 December 2020

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

1 reference

12 December 2020

Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells

1 reference

12 December 2020

Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

1 reference

12 December 2020

Molecular bases of the acute coronary syndromes

1 reference

12 December 2020

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

1 reference

12 December 2020

Hypercoagulable state in patients with hypercholesterolemia: effects of pravastatin

1 reference

12 December 2020

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

1 reference

12 December 2020

Effects of lipids and lipoproteins on thrombosis and rheology.

1 reference

12 December 2020

10.1007/S11886-999-0027-7

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1008584242

0 references

1 reference